Target intelligence / Profile preview

Free Radicals and Reactive Nitrogen Species (RNS)

Target
RNS
Molecular classification
Reactive species, Small molecules, Oxidants
01

Overview

Free Radicals and Reactive Nitrogen Species (RNS) are a family of antimicrobial and signaling molecules derived from nitric oxide (NO) and superoxide (O2•−) produced via the enzymatic activity of inducible nitric oxide synthase 2 (NOS2) and NADPH oxidase, respectively (Source: NCBI, PMC2820440). These species, including peroxynitrite (ONOO−) and nitrogen dioxide (•NO2), are highly reactive and can cause significant cellular damage through the nitration of proteins and peroxidation of lipids (Source: StatPearls, NBK541089). While they are essential for the immune system's 'oxidative burst' to kill pathogens, chronic elevation is linked to the pathogenesis of neurodegenerative diseases like Alzheimer's and cardiovascular conditions such as atherosclerosis (Source: PubMed, 21486303). Pharmacological intervention typically focuses on scavenging these radicals using antioxidants like Edaravone or inhibiting their production to mitigate tissue injury (Source: PubChem, CID 4021).

Other names
Reactive Nitrogen SpeciesRNSNitrosative stress agentsNitrogen-centered radicalsReactive Oxygen and Nitrogen Species
02

Mechanism of action

Drugs targeting these species primarily act through direct chemical scavenging, where the drug reacts with and neutralizes the radical, or by inhibiting enzymes like nitric oxide synthase (NOS) to prevent their formation (Source: PubMed, 15128444).

03

Biological functions

Signal transductionImmune responseApoptosisVasodilationNeurotransmission
04

Disease associations

CancerInflammationNeurodegenerative diseaseCardiovascular diseaseIschemia-reperfusion injury
05

Safety considerations

Interference with essential physiological signalingPotential for pro-oxidant effects at high dosesLack of specificity in scavengingAntioxidant paradox
06

Interacting drugs

Edaravone

6 more in the full profile.

07

Biomarkers

3-NitrotyrosineNitrite/Nitrate ratio8-IsoprostaneMalondialdehyde

Beyond the preview

Go deeper on Free Radicals and Reactive Nitrogen Species (RNS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Free Radicals and Reactive Nitrogen Species (RNS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call